CNXU
Conexeu Sciences Inc.
3.10$
+0.6%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | |
| – | +504.1% | +95.2% | +0.1% | -3.1% | +77.3% | -52.4% | – | |
| – | – | – | – | -100.0% | – | – | – | |
| – | +566.7% | -405.2% | – | -109.0% | – | -1,867.3% | – | |
| – | -64.8% | -91.6% | -100.0% | – | +534.2% | +37.6% | – | |
| – | – | – | -100.0% | – | – | – | – | |
| – | -118.6% | – | +225.1% | -23.5% | -29.0% | -29.7% | – | |
| – | -278.2% | – | +427.7% | -53.1% | -68.4% | -959.4% | – | |
| – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.